Jingjiu Health Therapy (00648) announced its interim results, with a net profit of HKD 4.648 million, an increase of 38.62% compared to the same period last year.

According to the Zhitong Finance APP, Beijing Jiukang Therapy (00648) announced its mid-term results for 2026, with revenue of HKD 34.075 million, a year-on-year decrease of 4.74%; net profit of HKD 4.648 million, a year-on-year increase of 38.62%; earnings per share of HKD 0.044.